Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of Montelukast and Neotadine in Allergic Rhinitis
IRCT20211205053277N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of montelukast in allergic rhinitis (AR) (2 arms), sponsored by Tehran University of Medical Sciences. Started May 2023; status: completed.
02
Drugs
montelukast
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on IRCT20211205053277N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20211205053277N1.